You are here

Generic version of Dasatinib coming?

As I understand it, the European patent for Dasatinib has been revoked and the patent owner's appeal was rejected earlier this year. Does anyone know if this means we will be seeing generic versions soon, rather than waiting until the patent was due to expire?

I understand there are other patents for the drug (the one revoked covered the active compound itself not the actual product and I think there is another one for specific use - I haven't looked but usually there is a cascade of patents covering a product, although in some cases e.g. imatinib these can be side stepped).  If there are further relevant patents it is likely still to be some time before generics can be available in Europe. There is also some regulatory protection which all new drugs get although this must be close to expiry if not already expired.